Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf380 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Robert L Atmar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Pandemics, Communicable Diseases, Emerging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Infectious Diseases Clinical Research Consortium, NIH HHS.
Abstract (Originalsprache)
Pathogens infecting humans continue to emerge or reemerge to cause outbreaks and widespread disease. The National Institute of Allergy and Infectious Diseases has funded Vaccine Treatment and Evaluation Units (VTEUs) for more than 50 years. VTEUs perform clinical studies to assess the safety and immunogenicity of candidate vaccines and other interventions to mitigate the impact of emerging and ongoing infectious diseases. Here, we review clinical studies conducted in the VTEUs since 2000 that have addressed emerging pathogens and other infectious agents with pandemic potential or of bioterrorism concern. The studies conducted range from phase 1 to phase 3 clinical trials, and they have included vaccines, therapeutics, and epidemiological studies. The results of the trials have guided national and often international recommendations for treatment and prevention of many of the evaluated pathogens, culminating in coronavirus disease 2019 studies that began within three months of severe acute respiratory syndrome coronavirus 2 identification. The VTEU network continues to be a critical public health resource for addressing emerging pathogens and expediting the development of safe and effective vaccines and treatments to protect at-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Center for Vaccine Development, Saint Louis University, St. Louis, Missouri, USA.
- Center for Vaccine Development and Global Health, The University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Internal Medicine, Saint Louis VA Medical Center, St. Louis, Missouri, USA.
- NYU Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
- Woodruff Health Sciences Center, Atlanta, Georgia, USA.
ORCID-Profile: Robert L Atmar, Getahun Abate, Meagan E Deming, Sarah L George, Andrew Fleming, Carlos Del Rio, Hana M El Sahly
Förderung
- NIAID NIH HHS
- Infectious Diseases Clinical Research Consortium
- NIH HHS
- Vaccine Treatment and Evaluation Units
- National Institute of Allergy and Infectious Diseases
- CSRD VA
- National Institutes of Health
Zitieren
APA
Atmar, R. L., Abate, G., Deming, M. E., George, S. L., Fleming, A., Frey, S. E., Lyke, K. E., Stephens, D. S., Del Rio, C., & El Sahly, H. M. (2025). Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf380
Vancouver
Atmar RL, Abate G, Deming ME, George SL, Fleming A, Frey SE, et al. Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf380
BibTeX
@article{Atmar2025,
author = {Atmar, Robert L and Abate, Getahun and Deming, Meagan E and George, Sarah L and Fleming, Andrew and Frey, Sharon E and Lyke, Kirsten E and Stephens, David S and Del Rio, Carlos and El Sahly, Hana M},
title = {Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf380}
}
EUVIMED